Marshall Wace North America’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Marshall Wace North America’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$107M	Buy	1,222,579 +287,275	+31%	+$26M	0.46%	42
2021 Q2	$83.7M	Buy	+935,304	New	+$79M	0.35%	60
2021 Q1	–	Sell	-72,690	Closed	-$4.95M	–	1858
2020 Q4	$4.95M	Buy	72,690 +32,170	+79%	+$2.01M	0.02%	541
2020 Q3	$2.15M	Buy	+40,520	New	+$2.41M	0.01%	563
2019 Q4	–	Sell	-5,148	Closed	-$274K	–	1687
2019 Q3	$274K	Sell	5,148 -11,175	-68%	-$573K	﹤0.01%	906
2019 Q2	$834K	Sell	16,323 -40,721	-71%	-$1.9M	0.01%	798
2019 Q1	$2.95M	Sell	57,044 -214,557	-79%	-$10.4M	0.02%	421
2018 Q4	$10.7M	Sell	271,601 -68,596	-20%	-$3.19M	0.1%	155
2018 Q3	$17.5M	Buy	+340,197	New	+$16.7M	0.12%	150
2018 Q2	–	Sell	-93,435	Closed	-$3.32M	–	1784
2018 Q1	$3.32M	Buy	+93,435	New	+$3.66M	0.02%	667
2017 Q4	–	Sell	-617,138	Closed	-$32.1M	–	1672
2017 Q3	$32.1M	Sell	617,138 -1,773	-0.3%	-$98.9K	0.2%	128
2017 Q2	$36.5M	Sell	618,911 -199,221	-24%	-$10.4M	0.27%	89
2017 Q1	$37.6M	Buy	+818,132	New	+$40.7M	0.3%	96

Other funds holding SYNH

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Marshall Wace North America's SYNH Position: Q3 2021 in Review

Marshall Wace North America increased its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 31% in Q3 2021, buying an estimated $26M and bringing the position to 1,222,579 shares worth $107M. The position accounts for 0.46% of the portfolio, ranked #42.

Marshall Wace North America first reported a position in SYNH in Q1 2017 and has held it in 13 quarters since. 355 funds tracked by Wall St. Rank hold SYNH as of Q3 2021.

Marshall Wace North America held 1,222,579 shares of Syneos Health, Inc. Class A Common Stock worth $107M as of Q3 2021.
Marshall Wace North America bought 287,275 Syneos Health, Inc. Class A Common Stock shares in Q3 2021, an estimated $26M.
Syneos Health, Inc. Class A Common Stock made up 0.46% of Marshall Wace North America's portfolio in Q3 2021, its #42 holding.
Marshall Wace North America first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and has held it in 13 quarters since.
355 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.